JPMorgan American (JAM) Competitors

GBX 980
-8.00 (-0.81%)
(As of 05/17/2024 07:35 PM ET)

JAM vs. TEM, HVPE, MRC, BPT, CLDN, WWH, PNL, FEV, WTAN, and RAT

Should you be buying JPMorgan American stock or one of its competitors? The main competitors of JPMorgan American include Templeton Emerging Mkts Invmt Tr TEMIT (TEM), HarbourVest Global Private Equity (HVPE), Mercantile (MRC), Bridgepoint Group (BPT), Caledonia Investments (CLDN), Worldwide Healthcare (WWH), Personal Assets Trust (PNL), Fidelity European Trust (FEV), Witan Investment Trust (WTAN), and Rathbones Group (RAT). These companies are all part of the "asset management" industry.

JPMorgan American vs.

Templeton Emerging Mkts Invmt Tr TEMIT (LON:TEM) and JPMorgan American (LON:JAM) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking.

Templeton Emerging Mkts Invmt Tr TEMIT has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, JPMorgan American has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.

JPMorgan American received 26 more outperform votes than Templeton Emerging Mkts Invmt Tr TEMIT when rated by MarketBeat users. Likewise, 65.07% of users gave JPMorgan American an outperform vote while only 55.65% of users gave Templeton Emerging Mkts Invmt Tr TEMIT an outperform vote.

CompanyUnderperformOutperform
Templeton Emerging Mkts Invmt Tr TEMITOutperform Votes
69
55.65%
Underperform Votes
55
44.35%
JPMorgan AmericanOutperform Votes
95
65.07%
Underperform Votes
51
34.93%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Templeton Emerging Mkts Invmt Tr TEMIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
JPMorgan American
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

JPMorgan American has a net margin of 96.44% compared to JPMorgan American's net margin of 83.81%. Templeton Emerging Mkts Invmt Tr TEMIT's return on equity of 13.31% beat JPMorgan American's return on equity.

Company Net Margins Return on Equity Return on Assets
Templeton Emerging Mkts Invmt Tr TEMIT83.81% 8.82% 5.55%
JPMorgan American 96.44%13.31%7.78%

JPMorgan American has lower revenue, but higher earnings than Templeton Emerging Mkts Invmt Tr TEMIT. JPMorgan American is trading at a lower price-to-earnings ratio than Templeton Emerging Mkts Invmt Tr TEMIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Templeton Emerging Mkts Invmt Tr TEMIT£200.31M9.09£167.88M£0.141,171.43
JPMorgan American£191.56M9.35£184.73M£0.99989.90

Templeton Emerging Mkts Invmt Tr TEMIT pays an annual dividend of GBX 5 per share and has a dividend yield of 3.0%. JPMorgan American pays an annual dividend of GBX 7 per share and has a dividend yield of 0.7%. Templeton Emerging Mkts Invmt Tr TEMIT pays out 3,571.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. JPMorgan American pays out 707.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, JPMorgan American had 3 more articles in the media than Templeton Emerging Mkts Invmt Tr TEMIT. MarketBeat recorded 4 mentions for JPMorgan American and 1 mentions for Templeton Emerging Mkts Invmt Tr TEMIT. JPMorgan American's average media sentiment score of 0.00 beat Templeton Emerging Mkts Invmt Tr TEMIT's score of -0.07 indicating that Templeton Emerging Mkts Invmt Tr TEMIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Templeton Emerging Mkts Invmt Tr TEMIT
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
JPMorgan American
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

68.1% of Templeton Emerging Mkts Invmt Tr TEMIT shares are held by institutional investors. Comparatively, 44.0% of JPMorgan American shares are held by institutional investors. 0.5% of Templeton Emerging Mkts Invmt Tr TEMIT shares are held by insiders. Comparatively, 6.3% of JPMorgan American shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

JPMorgan American beats Templeton Emerging Mkts Invmt Tr TEMIT on 12 of the 17 factors compared between the two stocks.

Get JPMorgan American News Delivered to You Automatically

Sign up to receive the latest news and ratings for JAM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JAM vs. The Competition

MetricJPMorgan AmericanAsset Management IndustryFinancial SectorLON Exchange
Market Cap£1.79B£729.01M£2.98B£1.43B
Dividend Yield0.73%13.28%4.63%11.84%
P/E Ratio989.90896.57464.231,675.23
Price / Sales9.3513,445.212,512.26309,991.83
Price / Cash35.0078.5348.0132.84
Price / Book1.241.752.242.71
Net Income£184.73M£48.49M£380.02M£174.61M
7 Day Performance-0.51%0.56%1.09%0.84%
1 Month Performance2.83%4.22%3.83%4.60%
1 Year Performance34.62%5.52%17.07%9.81%

JPMorgan American Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TEM
Templeton Emerging Mkts Invmt Tr TEMIT
0 of 5 stars
GBX 164.60
+0.6%
N/A+11.6%£1.83B£200.31M1,175.71N/A
HVPE
HarbourVest Global Private Equity
0 of 5 stars
GBX 2,280
-0.4%
N/A+3.9%£1.75B£171.22M-3,402.99N/A
MRC
Mercantile
0 of 5 stars
GBX 237
+0.2%
N/A+17.2%£1.84B£97.69M2,370.002,600Gap Up
BPT
Bridgepoint Group
0.6194 of 5 stars
GBX 234.40
+0.6%
GBX 249.50
+6.4%
+6.4%£1.86B£321.60M2,604.44391News Coverage
Gap Down
CLDN
Caledonia Investments
0 of 5 stars
GBX 3,460
-1.0%
N/A-3.1%£1.88B£167.60M1,510.9274News Coverage
Gap Up
WWH
Worldwide Healthcare
0 of 5 stars
GBX 349
-0.1%
N/A-89.4%£1.88B£-56,290,000.00-2,326.67N/A
PNL
Personal Assets Trust
0 of 5 stars
GBX 488
flat
N/A+2.6%£1.69B£-3,020,000.009,760.00N/ANews Coverage
Positive News
FEV
Fidelity European Trust
0 of 5 stars
GBX 407.50
+0.4%
N/A+13.6%£1.67B£263.57M702.59N/APositive News
WTAN
Witan Investment Trust
0 of 5 stars
GBX 267
+0.8%
N/A+15.0%£1.62B£207.95M953.576Positive News
RAT
Rathbones Group
0.6574 of 5 stars
GBX 1,772
flat
GBX 1,520
-14.2%
-10.8%£1.61B£676.20M3,474.513,500High Trading Volume

Related Companies and Tools

This page (LON:JAM) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners